Genetic Polymorphisms of <i>Toll-like receptors 2</i> and <i>9</i> as Susceptibility Factors for the Development of Ankylosing Spondylitis and Psoriatic Arthritis

Abstract

The polymorphism <i>rs5743708</i> for the <i>TLR2</i> and the <i>rs187084_rs5743836 TLR9</i> haplotypes appear to be involved in the development of clinical forms of SpA and can be a possible therapeutic target for the spondyloarthritis.